Cantor Fitzgerald Downgrades Galena Biopharma (GALE) to Sell on Recent Controversy
Tweet Send to a Friend
Cantor Fitzgerald downgraded Galena Biopharma (NASDAQ: GALE) from Hold to Sell with a price target of $3.50, saying concerns are ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
